Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique.
Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Wheeldon DR, et al. Among authors: oduro a. J Heart Lung Transplant. 1995 Jul-Aug;14(4):734-42. J Heart Lung Transplant. 1995. PMID: 7578183
Twenty-one of fifty-two had a mean arterial pressure less than 55 mm Hg (mean 47 mm Hg) despite inotropic support in most cases; 10 of 52 had a central venous pressure greater than 15 mm Hg (mean 18.0 mm Hg); 2 of 52 had a high inotrope requirement greater th …
Twenty-one of fifty-two had a mean arterial pressure less than 55 mm Hg (mean 47 mm Hg) despite inotropic support in most cases; 10 o …
Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery.
Snow DJ, Gray SJ, Ghosh S, Foubert L, Oduro A, Higenbottam TW, Wells FC, Latimer RD. Snow DJ, et al. Among authors: oduro a. Br J Anaesth. 1994 Feb;72(2):185-9. doi: 10.1093/bja/72.2.185. Br J Anaesth. 1994. PMID: 8110572
Nitric oxide caused a significant reduction in pulmonary vascular resistance after mitral valve surgery in patients who had pre-existing pulmonary hypertension, but no change in haemodynamic state in the coronary artery bypass group of patients, who had normal pulmonary ar …
Nitric oxide caused a significant reduction in pulmonary vascular resistance after mitral valve surgery in patients who had pre-exist …
Management of donors for heart and heart-lung transplantation.
Ghosh S, Bethune DW, Hardy I, Kneeshaw J, Latimer RD, Oduro A. Ghosh S, et al. Among authors: oduro a. Anaesthesia. 1990 Aug;45(8):672-5. doi: 10.1111/j.1365-2044.1990.tb14396.x. Anaesthesia. 1990. PMID: 2400080
Effects of intravenous enoximone following coronary artery bypass surgery.
Oduro A, Latimer RD, Davies A. Oduro A, et al. Cardiology. 1990;77 Suppl 3:42-5; discussion 62-7. doi: 10.1159/000174670. Cardiology. 1990. PMID: 2148279 Clinical Trial.
Results showed an improvement in cardiac index of approximately 35% and a reduction of systemic vascular resistance of approximately 30% in 10 out of 16 patients. In an attempt to explain the failure of 6 patients to respond to enoximone therapy, preliminary studies reveal …
Results showed an improvement in cardiac index of approximately 35% and a reduction of systemic vascular resistance of approximately …
Endotoxin-induced organ injury.
Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A. Ghosh S, et al. Among authors: oduro a. Crit Care Med. 1993 Feb;21(2 Suppl):S19-24. doi: 10.1097/00003246-199302001-00005. Crit Care Med. 1993. PMID: 8428492 Review.
DESIGN: Appraisal of 60 articles representing a cross section of studies relating to in vivo and in vitro responses to endotoxin. ...Species and tissue specificity are a prominent feature of the response to endotoxin. CONCLUSIONS: No single agent can yet be implicat …
DESIGN: Appraisal of 60 articles representing a cross section of studies relating to in vivo and in vitro responses to endotoxin. ... …
Management of low cardiac output syndrome after cardiac surgery using enoximone.
White DA, Latimer RD, Oduro A. White DA, et al. Among authors: oduro a. Anaesthesia. 1990 May;45(5):386-9. doi: 10.1111/j.1365-2044.1990.tb14783.x. Anaesthesia. 1990. PMID: 2141451
This case report describes the use of enoximone, a potent phosphodiesterase F-IV inhibitor with inotropic and vasodilator actions, to treat low output syndrome after cardiac surgery. The reduced cardiac output was unresponsive to a combination of inotropic drugs and …
This case report describes the use of enoximone, a potent phosphodiesterase F-IV inhibitor with inotropic and vasodilator actions, to …
The use of etomidate infusions during anaesthesia for cardiopulmonary bypass.
Oduro A, Tomlinson AA, Voice A, Davies GK. Oduro A, et al. Anaesthesia. 1983 Jul;38 Suppl:66-9. doi: 10.1111/j.1365-2044.1983.tb15183.x. Anaesthesia. 1983. PMID: 6869760
The effects of cardiopulmonary bypass and hypothermia were studied on the plasma concentration and metabolism of a continuous infusion of etomidate in six patients. Continuous etomidate infusions (20 micrograms/kg/minute) with analgesic cover may be a suitable anaes …
The effects of cardiopulmonary bypass and hypothermia were studied on the plasma concentration and metabolism of a continuous infusio …
Nitric oxide administration.
Moors AH, Pickett JA, Mahmood N, Latimer RD, Oduro A. Moors AH, et al. Among authors: oduro a. Anaesth Intensive Care. 1994 Jun;22(3):310-2. Anaesth Intensive Care. 1994. PMID: 8085638 No abstract available.
Safety of inhaled nitric oxide in premature neonates.
Ahluwalia JS, Kelsall AW, Raine J, Rennie JM, Mahmood M, Oduro A, Latimer R, Pickett J, Higenbottam TW. Ahluwalia JS, et al. Among authors: oduro a. Acta Paediatr. 1994 Mar;83(3):347-8. doi: 10.1111/j.1651-2227.1994.tb18115.x. Acta Paediatr. 1994. PMID: 8038549 No abstract available.
Design of nitric oxide delivery systems.
Powroznyk AV, Latimer RD, Oduro A. Powroznyk AV, et al. Among authors: oduro a. Br J Anaesth. 1995 Aug;75(2):253. doi: 10.1093/bja/75.2.253. Br J Anaesth. 1995. PMID: 7577269 No abstract available.
163 results
Jump to page
Feedback